Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT07193693
Recruiting Observational

Barriers Limiting OCT Penetration in Clinical Practice

NCT07193693 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2025-09-15
Last updated
2026-01-06

Condition(s) studied

Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))

Study summary

The updated guidelines from the European Society of Cardiology (ESC) for chronic coronary syndrome (CCS) have upgraded the use of IVUS and OCT to a class IA recommendation for complex PCI, based on evidence showing a reduction in serious clinical events, including mortality, compared to conventional angiography alone. Despite this, IVUS and OCT are underutilized in daily practice due to factors such as time, cost, and limited technology availability. Investigating the reasons behind this underuse is necessary, especially now that these technologies are more accessible and cost-effective. Additionally, OCT could be particularly helpful in specific cases such as coronary bifurcations and severe calcifications, warranting further evaluation of its use in these settings.

The objective of the study OCT2ACT is to investigate:

* The main reasons/barriers limiting the use of intracoronary imaging in complex PCI cases where it is indicated as suggested by guidelines;
* The main reasons behind the selection of IVUS or OCT in such patients;
* In cases where OCT is used, how this technology can influence the procedural planning and optimization in complex clinical settings.

The participating centers will include three cohorts of patients:

1. Cohort intracoronary imaging NO: patients who meet the inclusion/exclusion criteria, but did not undergo intracoronary imaging (IVUS or OCT) due to operator's decision.

The aim is to describe the main reasons/barriers for not using imaging.
2. Cohort intracoronary imaging YES according to guidelines recommendation: patients who meet the inclusion/exclusion criteria and underwent intracoronary imaging as recommended by guidelines.

The aim is to understand the main reasons for the decision to use IVUS or OCT and the clinical benefits perceived by the operator.
3. Cohort intracoronary imaging YES outside guidelines recommendation: patients who meet the inclusion/exclusion criteria and underwent intracoronary imaging (IVUS or OCT) outside.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
1. Cohort intracoronary imaging NO • Inclusion criteria Patients undergoing clinically indicated PCI and having at least one of the following criteria (suggestive for complex PCI) without receiving intracoronary imaging: * Long lesion (\>38 mm) * True bifurcation involving side-branch with a reference diameter of \>2.5 mm and Medina 1.1.1 * Left main bifurcation • Exclusion criteria * Refusal of informed consent 2. Cohort intracoronary imaging YES according to guidelines recommendation • Inclusion criteria Patients undergoing clinically indicated PCI with the guidance of intracoronary imaging (OCT or IVUS) and having at least one of the following criteria (suggestive for complex PCI) receiving imaging: * Long lesion (\>38 mm) * True bifurcation involving side-branch with a reference diameter of \>2.5 mm and Medina 1.1.1 * Left main bifurcation • Exclusion criteria * Refusal of informed consent 3. Cohort intracoronary imaging YES outside guidelines recommendation * Inclusion criteria Patients undergoing IVUS or OCT use. * Exclusion criteria * Long lesion (\>38 mm) * True bifurcation involving side-branch with a reference diameter of \>2.5 mm and Medina 1.1.1 * Left main bifurcation * Refusal of informed consent

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
ASST Papa Giovanni XXIII Bergamo Italy Recruiting
Ospedale San Martino Genova Italy Recruiting

More Consorzio Futuro in Ricerca trials in Italy

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07193693 on ClinicalTrials.gov ↗ ← All trials in Italy